BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29269682)

  • 1. Autoimmune Hemolytic Anemia Obscured by the Obstructive Jaundice Associated with IgG4-related Sclerosing Cholangitis in a Patient with Type 1 Autoimmune Pancreatitis: A Case Report and Review of the Literature.
    Yoshida M; Marumo Y; Naitoh I; Hayashi K; Miyabe K; Nishi Y; Fujita Y; Jinno N; Hori Y; Natsume M; Kato A; Iida S; Joh T
    Intern Med; 2018 Jun; 57(12):1725-1732. PubMed ID: 29269682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG4-positive sclerosing cholangitis following autoimmune pancreatitis with deranged CA19.9.
    Ong SL; Garcea G; Puls F; Richards C; Mulcahy K; Grant A; Dennison AR; Berry DP
    Int J Surg Pathol; 2011 Feb; 19(1):84-7. PubMed ID: 18611930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First case of IgG4-related sclerosing cholangitis associated with autoimmune hemolytic anemia.
    Masutani H; Okuwaki K; Kida M; Yamauchi H; Imaizumi H; Miyazawa S; Iwai T; Takezawa M; Koizumi W
    World J Gastroenterol; 2014 Jul; 20(26):8740-4. PubMed ID: 25024635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.
    Takuma K; Kamisawa T; Igarashi Y
    Curr Opin Rheumatol; 2011 Jan; 23(1):80-7. PubMed ID: 21124090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG4 negative sclerosing cholangitis associated with autoimmune pancreatitis.
    Sewkani A; Kapoor S; Sharma S; Naik S; Debbarma MK; Varshney S
    JOP; 2005 May; 6(3):269-73. PubMed ID: 15883479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
    Lin J; Cummings OW; Greenson JK; House MG; Liu X; Nalbantoglu I; Pai R; Davidson DD; Reuss SA
    Scand J Gastroenterol; 2015 Apr; 50(4):447-53. PubMed ID: 25635498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical observation of isolated immunoglobulin G4-related sclerosing cholangitis and immunoglobulin G4 sclerosing cholangitis combined autoimmune pancreatitis].
    Jiang P; Lian M; Li B; Xiao X; Miao Q; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):415-419. PubMed ID: 30317753
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
    Nishimori I; Otsuki M
    Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis.
    Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K
    World J Gastroenterol; 2009 May; 15(19):2357-60. PubMed ID: 19452578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary and hepatic involvement in IgG4-related disease.
    Joshi D; Webster GJ
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1251-61. PubMed ID: 25312536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endoscopy in the diagnosis of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis.
    Kamisawa T; Ohara H; Kim MH; Kanno A; Okazaki K; Fujita N
    Dig Endosc; 2014 Sep; 26(5):627-35. PubMed ID: 24712522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
    Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
    J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features.
    Kubota K; Kato S; Akiyama T; Yoneda M; Fujita K; Ogawa M; Inamori M; Kobayashi N; Saito S; Kakuta Y; Ohshiro H; Nakajima A
    Gastrointest Endosc; 2008 Dec; 68(6):1204-8. PubMed ID: 19028233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis.
    Nishino T; Oyama H; Hashimoto E; Toki F; Oi I; Kobayashi M; Shiratori K
    J Gastroenterol; 2007 Jul; 42(7):550-9. PubMed ID: 17653651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Pancreatitis and Immunoglobulin G4-related Sclerosing Cholangitis: Past, Present, and Future.
    Moon SH; Kim MH
    Korean J Gastroenterol; 2022 Sep; 80(3):107-114. PubMed ID: 36156034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis.
    Detlefsen S; Klöppel G
    Virchows Arch; 2018 Apr; 472(4):545-556. PubMed ID: 29196804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune pancreatitis and IgG-positive sclerosing cholangitis].
    Díte P; Novotný I; Lata J; Růzicka M; Geryk E; Kianicka B
    Vnitr Lek; 2011 Mar; 57(3):254-7. PubMed ID: 21495406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4-related sclerosing disease: autoimmune pancreatitis (AIP) and IgG4-related cholangitis.
    Dechoux S; Arrivé L
    Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):601. PubMed ID: 21963087
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort.
    Huggett MT; Culver EL; Kumar M; Hurst JM; Rodriguez-Justo M; Chapman MH; Johnson GJ; Pereira SP; Chapman RW; Webster GJM; Barnes E
    Am J Gastroenterol; 2014 Oct; 109(10):1675-1683. PubMed ID: 25155229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.